Clinical Trial Update: MIBG in Aging and Neurologic Disorders [Phase 4]

View source ↗

Summary

Mayo Clinic is leading a Phase 4 trial of MIBG in aging and neurologic disorders, with enrollment by invitation, studying Lewy body dementia, dementia, Parkinso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia
• Lewy Body Dementia
• Parkinson Disease
• Rem Sleep Behavior Disorder

Drugs mentioned

• MIBG (metaiodobenzylguanidine)

Snippet

Sponsor: Mayo Clinic | Conditions: Lewy Body Disease, Dementia | Phase 4 | Status: ENROLLING_BY_INVITATION